Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
Promis Neurosciences Inc. | -8.190% | -16.489% | -10.286% | -68.219% | 57.789% | -76.741% | -84.331% |
InMed Pharmaceuticals Inc. | 5.990% | 19.158% | 9.690% | -76.917% | -17.733% | -99.476% | -99.883% |
Resverlogix Corp | -1.370% | -1.370% | -1.370% | -57.143% | -16.279% | -93.846% | -98.392% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat